Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application

Jian Yin; Yi Wang; Hanlu Yin; Wenping Chen; Guangfu Jin; Hongxia Ma; Juncheng Dai; Jiaping Chen; Yue Jiang; Hui Wang; Zhian Liu; Zhibin Hu; Hongbing Shen

doi:10.1371/journal.pone.0137076

Loading metrics

Open Access

Peer-reviewed

Research Article

Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application

Jian Yin ,

Contributed equally to this work with: Jian Yin, Yi Wang, Hanlu Yin, Wenping Chen

Affiliations Department of Epidemiology & Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China
⨯
Yi Wang ,

Contributed equally to this work with: Jian Yin, Yi Wang, Hanlu Yin, Wenping Chen

Affiliation Department of Respiratory Diseases, Nanjing Chest Hospital, Nanjing, China
⨯
Hanlu Yin ,

Contributed equally to this work with: Jian Yin, Yi Wang, Hanlu Yin, Wenping Chen

Affiliations Department of Epidemiology & Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China
⨯
Wenping Chen ,

Contributed equally to this work with: Jian Yin, Yi Wang, Hanlu Yin, Wenping Chen

Affiliation Department of Respiratory Diseases, Nanjing Chest Hospital, Nanjing, China
⨯
Guangfu Jin,

Affiliations Department of Epidemiology & Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China
⨯
Hongxia Ma,

Affiliations Department of Epidemiology & Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China
⨯
Juncheng Dai,

Affiliations Department of Epidemiology & Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China
⨯
Jiaping Chen,

Affiliations Department of Epidemiology & Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China
⨯
Yue Jiang,

Affiliations Department of Epidemiology & Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China
⨯
Hui Wang,

Affiliations Department of Epidemiology & Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China
⨯
Zhian Liu ,

* E-mail: liuz@njmu.edu.cn (ZL); zhibin_hu@njmu.edu.cn (ZH); hbshen@njmu.edu.cn (HS)

Affiliations Department of Epidemiology & Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China
⨯
Zhibin Hu ,

* E-mail: liuz@njmu.edu.cn (ZL); zhibin_hu@njmu.edu.cn (ZH); hbshen@njmu.edu.cn (HS)

Affiliations Department of Epidemiology & Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China
⨯
Hongbing Shen

* E-mail: liuz@njmu.edu.cn (ZL); zhibin_hu@njmu.edu.cn (ZH); hbshen@njmu.edu.cn (HS)

Affiliations Department of Epidemiology & Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China
⨯

Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application

Jian Yin,
Yi Wang,
Hanlu Yin,
Wenping Chen,
Guangfu Jin,
Hongxia Ma,
Juncheng Dai,
Jiaping Chen,
Yue Jiang,
Hui Wang

Published: August 28, 2015
https://doi.org/10.1371/journal.pone.0137076

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Blood
Is the Subject Area "Blood" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
White blood cells
Is the Subject Area "White blood cells" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Progressive diseases
Is the Subject Area "Progressive diseases" applicable to this article?

Thanks for your feedback.
Cancer stem cells
Is the Subject Area "Cancer stem cells" applicable to this article?

Thanks for your feedback.
Flow cytometry
Is the Subject Area "Flow cytometry" applicable to this article?

Thanks for your feedback.